7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      assets
    		                   
      investments:
    		                   
      fixed maturities available-for-sale, at fair value
    		245,500,000 237,300,000 212,200,000 205,700,000 201,800,000 167,000,000 162,700,000 161,700,000 141,500,000 135,600,000 141,000,000 121,100,000 109,200,000 102,600,000 86,500,000 54,900,000 59,700,000   
      short-term investments, at fair value
    		174,700,000 167,800,000 175,400,000 167,600,000 152,500,000 148,500,000 124,700,000  188,500,000 228,800,000 290,400,000         
      total investments
    		420,200,000 405,100,000 387,600,000 373,300,000 354,300,000 315,500,000 287,400,000 348,800,000 330,000,000 364,400,000 431,400,000 445,900,000 330,800,000 454,300,000 435,400,000 64,000,000 72,000,000   
      cash and cash equivalents
    		247,700,000 198,900,000 140,900,000 197,600,000 191,200,000 175,900,000 223,400,000 142,100,000 228,400,000 200,200,000 188,900,000 194,500,000 346,500,000 277,500,000 336,800,000 775,600,000 778,700,000   
      restricted cash
    		24,500,000 26,900,000 39,300,000 35,200,000 39,700,000 44,300,000 39,900,000 53,000,000 41,000,000 38,200,000 31,800,000 50,000,000 46,400,000 47,000,000 44,800,000 43,100,000 44,100,000   
      accounts receivable
    		236,700,000 227,100,000 172,800,000 167,000,000 157,800,000 167,400,000 153,800,000 145,200,000 145,400,000 148,200,000 133,600,000 107,200,000 89,800,000 66,600,000 61,000,000 56,500,000 60,300,000   
      reinsurance recoverable on paid and unpaid losses and lae
    		321,300,000 302,600,000 326,000,000 285,300,000 279,800,000 290,800,000 290,100,000 281,300,000 297,300,000 332,700,000 300,600,000 286,300,000 337,300,000 291,400,000 321,400,000 266,900,000 279,400,000   
      prepaid reinsurance premiums
    		336,600,000 296,400,000 249,300,000 274,200,000 292,300,000 291,300,000 275,300,000 335,600,000 375,500,000 375,200,000 326,800,000 309,900,000 301,600,000 263,400,000 236,000,000 231,600,000 228,100,000   
      ceding commissions receivable
    		123,100,000 107,700,000 85,700,000 79,500,000 89,000,000 81,700,000 82,200,000 73,800,000 79,900,000 70,100,000 59,900,000 45,800,000 56,300,000 50,000,000 49,200,000 41,600,000 38,000,000   
      capitalized internal use software
    		43,300,000 47,200,000 47,400,000 48,100,000 50,200,000 49,900,000 48,900,000 48,400,000 46,900,000 44,000,000 41,200,000 38,800,000 36,800,000 34,000,000 30,300,000 25,900,000 21,600,000   
      intangible assets
    		14,000,000 14,300,000 16,100,000 17,000,000 23,800,000 25,000,000 26,200,000 27,300,000 23,600,000 24,700,000 25,800,000 26,900,000 28,000,000 29,200,000 30,300,000 32,200,000 33,700,000   
      other assets
    		106,200,000 75,300,000 75,300,000 66,200,000 67,300,000 68,500,000 69,100,000 69,200,000 79,000,000 83,100,000 64,700,000 63,600,000 56,500,000 62,500,000 75,800,000 51,800,000 49,100,000   
      total assets
    		1,873,600,000 1,706,200,000 1,540,400,000 1,543,400,000 1,545,400,000 1,510,300,000 1,496,300,000 1,524,700,000 1,647,000,000 1,680,800,000 1,604,700,000 1,568,900,000 1,630,000,000 1,629,400,000 1,674,500,000 1,642,700,000 1,658,200,000 230,905,463 231,219,945 
      liabilities and stockholders’ equity
    		                   
      liabilities:
    		                   
      loss and loss adjustment expense reserve
    		384,400,000 389,000,000 400,800,000 350,000,000 351,100,000 346,900,000 336,600,000 322,500,000 359,900,000 367,600,000 305,200,000 293,800,000 321,500,000 268,800,000 282,400,000 260,800,000 239,700,000   
      unearned premiums
    		564,400,000 506,200,000 446,000,000 457,900,000 473,800,000 452,700,000 407,300,000 419,200,000 441,800,000 423,100,000 365,700,000 341,300,000 316,500,000 282,900,000 252,100,000 253,100,000 244,300,000   
      reinsurance premiums payable
    		332,100,000 302,900,000 238,300,000 248,600,000 261,200,000 246,600,000 263,200,000 260,100,000 291,100,000 302,700,000 249,500,000 207,100,000 215,900,000 192,400,000 201,700,000 159,400,000 162,100,000   
      benefit from commission
    		38,000,000 38,400,000 38,700,000 34,300,000 31,100,000 31,300,000 29,000,000 24,700,000 18,000,000 12,700,000 8,700,000 5,000,000 13,400,000 13,300,000 14,400,000 12,300,000 11,200,000   
      surplus note
    		47,900,000 47,900,000                  
      accrued expenses and other liabilities
    		85,300,000 77,200,000 90,900,000 87,400,000 98,100,000 106,200,000 105,400,000 113,500,000 124,900,000 127,700,000 132,600,000 128,200,000 123,700,000 120,600,000 101,100,000 83,800,000 61,900,000   
      total liabilities
    		1,452,100,000 1,372,100,000 1,214,700,000 1,178,200,000 1,215,300,000 1,183,700,000 1,141,500,000 1,140,000,000 1,235,700,000 1,233,800,000 1,061,700,000 975,400,000 991,000,000 878,000,000 865,800,000 781,000,000 754,500,000 26,151,898 23,834,287 
      commitments and contingencies
    		                   
      stockholders’ equity:
    		                   
      common stock
    		                   
      additional paid-in capital
    		1,643,300,000 1,653,700,000 1,646,000,000 1,639,700,000 1,645,100,000 1,636,800,000 1,624,700,000 1,615,200,000 1,606,100,000 1,590,900,000 1,574,700,000 1,558,000,000 1,540,800,000 1,522,800,000 1,504,400,000 1,488,300,000 1,469,100,000 11,565,268 8,933,205 
      accumulated other comprehensive income
    		1,400,000 100,000              -700,000 -400,000   
      accumulated deficit
    		-1,223,200,000 -1,321,300,000 -1,322,600,000 -1,274,900,000 -1,319,200,000 -1,310,600,000 -1,270,100,000 -1,234,400,000 -1,192,000,000 -1,138,900,000 -1,031,100,000 -961,100,000 -898,000,000 -768,800,000 -695,600,000 -628,000,000 -567,300,000 -6,566,141 -3,934,048 
      total hippo stockholders’ equity
    		421,500,000 332,500,000 322,800,000  326,400,000 322,600,000 351,200,000  407,000,000 445,600,000 538,300,000  635,000,000 749,100,000 805,500,000     
      noncontrolling interest
    		 1,600,000 2,900,000 3,100,000 3,700,000 4,000,000 3,600,000 6,800,000 4,300,000 1,400,000 4,700,000 3,600,000 4,000,000 2,300,000 3,200,000 2,100,000 2,300,000   
      total stockholders’ equity
    		421,500,000 334,100,000 325,700,000 365,200,000 330,100,000 326,600,000 354,800,000 384,700,000 411,300,000 447,000,000 543,000,000 593,500,000 639,000,000 751,400,000 808,700,000 861,700,000 903,700,000   
      total liabilities and stockholders’ equity
    		1,873,600,000 1,706,200,000 1,540,400,000 1,543,400,000 1,545,400,000 1,510,300,000 1,496,300,000 1,524,700,000 1,647,000,000 1,680,800,000 1,604,700,000 1,568,900,000 1,630,000,000 1,629,400,000 1,674,500,000     
      assets held for sale
    		 4,700,000                  
      liabilities held for sale
    		 10,500,000                  
      accumulated other comprehensive loss
    		  -600,000 -2,700,000 500,000 -3,600,000 -3,400,000 -2,900,000 -7,100,000 -6,400,000 -5,300,000 -7,000,000 -7,800,000 -4,900,000 -3,300,000     
      stockholders’ equity
    		                   
      total hippo stockholders' equity
    		   362,100,000    377,900,000    589,900,000    859,600,000 901,400,000   
      short-term investments
    		       187,100,000    324,800,000 221,600,000 351,700,000 348,900,000 9,100,000 12,300,000   
      goodwill
    		             53,500,000 53,500,000 53,500,000 53,200,000   
      contingent consideration liability
    		              14,100,000 11,600,000 11,500,000   
      liabilities, convertible preferred stock, and stockholders’ equity
    		                   
      convertible promissory notes
    		                   
      derivative liability on notes
    		                   
      preferred stock warrant liabilities
    		                   
      convertible preferred stock:
    		                   
      preferred stock, 0.0001 par value per share; 10,000,000 and 323,232,460 shares authorized as of december 31, 2021 and december 31, 2020, respectively; 0 and 305,887,443 shares issued and outstanding as of december 31, 2021 and december 31, 2020, respectively; liquidation preferences of 0 and 359.4 million as of december 31, 2021 and december 31, 2020, respectively
    		                   
      total liabilities, convertible preferred stock, and stockholders’ equity
    		               1,642,700,000 1,658,200,000   
      fiduciary liabilities
    		                23,800,000   
      preferred stock, 0.0001 par value per share; 10,000,000 and 323,232,460 shares authorized as of september 30, 2021 and december 31, 2020, respectively; 0 and 305,887,443 shares issued and outstanding as of september 30, 2021 and december 31, 2020, respectively; liquidation preferences of 0 and 359.4 million as of september 30, 2021 and december 31, 2020, respectively
    		                   
      assets:
    		                   
      current assets:
    		                   
      cash
    		                 101,045 214,015 
      prepaid expenses
    		                 800,310 934,320 
      total current assets
    		                 901,355 1,148,335 
      cash and investments held in trust account
    		                 230,004,108 230,071,610 
      liabilities and shareholders’ equity:
    		                   
      current liabilities:
    		                   
      accounts payable
    		                 89,189 22,500 
      accrued expenses
    		                 874,866 866,866 
      due to related party
    		                 334,663 168,661 
      total current liabilities
    		                 1,298,718 1,058,027 
      deferred legal fees
    		                 200,000 200,000 
      deferred underwriting commissions
    		                 8,050,000 8,050,000 
      derivative warrant liabilities
    		                 16,603,180 14,526,260 
      class a ordinary shares; 19,975,356 and 20,484,749 shares subject to possible redemption at 10.00 per share at june 30, 2021 and december 31, 2020, respectively
    		                 199,753,560  
      shareholders’ equity:
    		                   
      preference shares, 0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
    		                   
      class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 3,024,644 and 2,515,251 shares issued and outstanding (excluding 19,975,356 and 20,484,749 shares subject to possible
    		                 303  
      redemption) at june 30, 2021 and december 31, 2020, respectively
    		                   
      class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding at june 30, 2021 and december 31, 2020
    		                 575  
      total shareholders’ equity
    		                 5,000,005 5,000,008 
      total liabilities and shareholders’ equity
    		                 230,905,463 231,219,945 
      class a ordinary shares; 20,238,565 and 20,484,749 shares subject to possible redemption at 10.00 per share at march 31, 2021 and december 31, 2020, respectively
    		                  202,385,650 
      class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 2,761,435 and 2,515,251 shares issued and outstanding (excluding 20,238,565 and 20,484,749 shares subject to possible redemption) at march 31, 2021 and december 31, 2020, respectively
    		                  276 
      class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding at march 31, 2021 and december 31, 2020
    		                  575 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.